Medicine - صفحه 4

Medicine
Exercise Pill

An ‘Exercise Pill’ Just Cleared Its First Human Test

Enveda announced positive Phase I results of its drug ENV-308, which mimics a molecule naturally produced during exercise.
News ID: 844   Publish Date : 2026/08/20

Exercise Pill

An ‘Exercise Pill’ Just Cleared Its First Human Test

Enveda announced positive Phase I results of its drug ENV-308, which mimics a molecule naturally produced during exercise.
News ID: 844   Publish Date : 2026/08/20

Exercise Pill

An ‘Exercise Pill’ Just Cleared Its First Human Test

Enveda announced positive Phase I results of its drug ENV-308, which mimics a molecule naturally produced during exercise.
News ID: 844   Publish Date : 2026/08/20

Exercise Pill

An ‘Exercise Pill’ Just Cleared Its First Human Test

Enveda announced positive Phase I results of its drug ENV-308, which mimics a molecule naturally produced during exercise.
News ID: 844   Publish Date : 2026/08/20

Exercise Pill

An ‘Exercise Pill’ Just Cleared Its First Human Test

Enveda announced positive Phase I results of its drug ENV-308, which mimics a molecule naturally produced during exercise.
News ID: 844   Publish Date : 2026/08/20

Exercise Pill

An ‘Exercise Pill’ Just Cleared Its First Human Test

Enveda announced positive Phase I results of its drug ENV-308, which mimics a molecule naturally produced during exercise.
News ID: 844   Publish Date : 2026/08/20

Exercise Pill

An ‘Exercise Pill’ Just Cleared Its First Human Test

Enveda announced positive Phase I results of its drug ENV-308, which mimics a molecule naturally produced during exercise.
News ID: 844   Publish Date : 2026/08/20

Exercise Pill

An ‘Exercise Pill’ Just Cleared Its First Human Test

Enveda announced positive Phase I results of its drug ENV-308, which mimics a molecule naturally produced during exercise.
News ID: 844   Publish Date : 2026/08/20

Exercise Pill

An ‘Exercise Pill’ Just Cleared Its First Human Test

Enveda announced positive Phase I results of its drug ENV-308, which mimics a molecule naturally produced during exercise.
News ID: 844   Publish Date : 2026/08/20

Exercise Pill

An ‘Exercise Pill’ Just Cleared Its First Human Test

Enveda announced positive Phase I results of its drug ENV-308, which mimics a molecule naturally produced during exercise.
News ID: 844   Publish Date : 2026/08/20

Exercise Pill

An ‘Exercise Pill’ Just Cleared Its First Human Test

Enveda announced positive Phase I results of its drug ENV-308, which mimics a molecule naturally produced during exercise.
News ID: 844   Publish Date : 2026/08/20

Exercise Pill

An ‘Exercise Pill’ Just Cleared Its First Human Test

Enveda announced positive Phase I results of its drug ENV-308, which mimics a molecule naturally produced during exercise.
News ID: 844   Publish Date : 2026/08/20

Exercise Pill

An ‘Exercise Pill’ Just Cleared Its First Human Test

Enveda announced positive Phase I results of its drug ENV-308, which mimics a molecule naturally produced during exercise.
News ID: 844   Publish Date : 2026/08/20

Exercise Pill

An ‘Exercise Pill’ Just Cleared Its First Human Test

Enveda announced positive Phase I results of its drug ENV-308, which mimics a molecule naturally produced during exercise.
News ID: 844   Publish Date : 2026/08/20

Exercise Pill

An ‘Exercise Pill’ Just Cleared Its First Human Test

Enveda announced positive Phase I results of its drug ENV-308, which mimics a molecule naturally produced during exercise.
News ID: 844   Publish Date : 2026/08/20

AI

The Most Important Thing AI Can’t Do in Medicine

I was an early medical student at the University of Miami in Florida, seeing a patient in a local primary care clinic. “Abdominal pain with constipation,” I proudly told my supervising physician. “I think it’s irritable bowel syndrome.”
News ID: 812   Publish Date : 2026/08/16

Health

Second expo on advanced technologies in Persian medicine to be held

ECONEWS – The second exhibition on Iran's advanced technologies in Persian medicine (known as Farre Iran) will be held to introduce the country’s technological and knowledge-based products.
News ID: 115   Publish Date : 2026/05/11

Health insurance provided for some 2m patients with rare, hard-to-treat diseases

ECONEWS – According to the health ministry, about two million patients with rare and hard-to-treat diseases are covered by the Health Insurance Organization.
News ID: 109   Publish Date : 2026/05/10

National Health Week to be marked

ECONEWS – The national health week is scheduled to be held from May 15 to 21, under the theme ‘sustainable healthcare with science and authority, enduring Iran’.
News ID: 65   Publish Date : 2026/05/09